TipRanks
Ildong Pharmaceutical Co., Ltd. (KR:249420)
:249420
South Korea Market
249420
Ildong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Ildong Pharmaceutical Co., Ltd. (249420) Ratios

― Followers

Ildong Pharmaceutical Co., Ltd. Ratios

KR:249420's free cash flow for Q2 2026 was ₩0.38. For the 2026 fiscal year, KR:249420's free cash flow was decreased by ₩ and operating cash flow was ₩0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.00 0.96 0.90 0.68 0.89
Quick Ratio
 0.56 0.53 0.58 0.44 0.58
Cash Ratio
 0.24 0.28 0.26 0.15 0.16
Solvency Ratio
 0.21 0.15 0.05 -0.12 -0.25
Operating Cash Flow Ratio
 0.16 0.08 0.10 -0.11 -0.17
Short-Term Operating Cash Flow Coverage
 0.29 0.16 0.22 -0.19 -0.38
Net Current Asset Value
₩ -92.37B₩ -111.55B₩ -182.99B₩ -201.31B₩ -175.55B
Leverage Ratios
Debt-to-Assets Ratio
 0.25 0.26 0.35 0.35 0.32
Debt-to-Equity Ratio
 0.55 0.61 1.28 1.25 1.09
Debt-to-Capital Ratio
 0.36 0.38 0.56 0.56 0.52
Long-Term Debt-to-Capital Ratio
 0.00 0.01 0.26 0.02 0.08
Financial Leverage Ratio
 2.17 2.33 3.66 3.61 3.43
Debt Service Coverage Ratio
 -0.10 0.25 0.22 -0.19 -0.68
Interest Coverage Ratio
 3.20 1.42 0.73 -3.63 -7.49
Debt to Market Cap
 0.26 0.10 0.55 0.40 0.22
Interest Debt Per Share
 7.40K 5.41K 8.01K 8.41K 8.26K
Net Debt to EBITDA
 -16.06 2.14 3.97 -3.11 -1.93
Profitability Margins
Gross Profit Margin
38.39%37.88%37.96%34.55%37.06%
EBIT Margin
-4.74%3.06%1.24%-13.24%-17.25%
EBITDA Margin
-0.95%7.04%5.46%-8.53%-12.62%
Operating Profit Margin
4.39%3.06%2.13%-8.89%-11.50%
Pretax Profit Margin
8.08%5.61%-1.74%-15.69%-18.79%
Net Profit Margin
7.49%4.88%-0.74%-13.14%-22.29%
Continuous Operations Profit Margin
6.80%4.18%-2.02%-13.48%-22.29%
Net Income Per EBT
92.68%86.99%42.80%83.72%118.65%
EBT Per EBIT
184.23%183.60%-81.50%176.48%163.40%
Return on Assets (ROA)
7.78%4.83%-0.78%-12.91%-21.68%
Return on Equity (ROE)
17.72%11.23%-2.85%-46.55%-74.34%
Return on Capital Employed (ROCE)
7.46%5.06%4.19%-20.18%-21.60%
Return on Invested Capital (ROIC)
4.63%2.79%2.96%-10.02%-15.03%
Return on Tangible Assets
8.23%5.08%-0.83%-13.87%-23.36%
Earnings Yield
9.30%2.39%-1.39%-16.25%-19.88%
Efficiency Ratios
Receivables Turnover
 9.84 10.48 8.68 9.07 10.28
Payables Turnover
 8.83 7.37 8.01 7.83 8.71
Inventory Turnover
 3.74 3.50 4.34 4.65 4.09
Fixed Asset Turnover
 2.70 2.57 2.78 2.34 2.50
Asset Turnover
 1.04 0.99 1.04 0.98 0.97
Working Capital Turnover Ratio
 -1.12K -29.86 -8.80 -8.28 -13.17
Cash Conversion Cycle
 93.35 89.52 80.63 72.17 82.92
Days of Sales Outstanding
 37.10 34.84 42.05 40.26 35.50
Days of Inventory Outstanding
 97.58 104.19 84.14 78.55 89.35
Days of Payables Outstanding
 41.33 49.50 45.56 46.64 41.92
Operating Cycle
 134.68 139.02 126.19 118.81 124.85
Cash Flow Ratios
Operating Cash Flow Per Share
 1.75K 630.95 1.01K -1.35K -2.03K
Free Cash Flow Per Share
 1.17K 176.60 509.82 -2.03K -2.78K
CapEx Per Share
 577.64 454.36 503.09 672.90 744.21
Free Cash Flow to Operating Cash Flow
 0.67 0.28 0.50 1.50 1.37
Dividend Paid and CapEx Coverage Ratio
 1.97 1.39 2.00 -2.00 -2.71
Capital Expenditure Coverage Ratio
 3.03 1.39 2.01 -2.01 -2.73
Operating Cash Flow Coverage Ratio
 0.25 0.13 0.14 -0.17 -0.26
Operating Cash Flow to Sales Ratio
 0.06 0.03 0.05 -0.06 -0.08
Free Cash Flow Yield
5.05%0.46%4.33%-11.28%-10.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.23 40.87 -71.93 -6.15 -5.03
Price-to-Sales (P/S) Ratio
 0.79 2.04 0.53 0.81 1.12
Price-to-Book (P/B) Ratio
 1.14 4.69 2.05 2.86 3.74
Price-to-Free Cash Flow (P/FCF) Ratio
 19.26 218.01 23.09 -8.86 -9.78
Price-to-Operating Cash Flow Ratio
 8.30 61.02 11.62 -13.27 -13.36
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.06 0.76 0.13 -0.18
Price-to-Fair Value
 1.14 4.69 2.05 2.86 3.74
Enterprise Value Multiple
 -98.85 31.12 13.76 -12.59 -10.82
Enterprise Value
 558.16B 1.24T 462.04B 645.20B 870.84B
EV to EBITDA
 -101.08 31.12 13.76 -12.59 -10.82
EV to Sales
 0.96 2.19 0.75 1.07 1.37
EV to Free Cash Flow
 23.52 234.12 32.45 -11.77 -11.91
EV to Operating Cash Flow
 15.75 65.53 16.33 -17.62 -16.27
Tangible Book Value Per Share
 10.81K 7.02K 4.46K 4.89K 5.74K
Shareholders’ Equity Per Share
 12.72K 8.20K 5.76K 6.27K 7.26K
Tax and Other Ratios
Effective Tax Rate
 0.16 0.25 -0.16 0.14 -0.19
Revenue Per Share
 28.72K 18.88K 22.02K 22.23K 24.21K
Net Income Per Share
 2.15K 921.07 -163.83 -2.92K -5.40K
Tax Burden
 0.93 0.87 0.43 0.84 1.19
Interest Burden
 -1.71 1.84 -1.40 1.19 1.09
Research & Development to Revenue
 0.05 0.06 0.08 0.16 0.17
SG&A to Revenue
 0.15 0.14 0.15 0.14 0.17
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 0.00 <0.01
Income Quality
 0.83 0.69 -2.28 0.46 0.38
Currency in KRW